Nuformix PLC (NFX)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

0.17p

Buy

0.20p

arrow-up0.00p (+0.00%)

Prices updated at 10 Jun 2026, 16:23 BST

Prices minimum 15 mins delay

Prices in GBX

Nuformix PLC is a pharmaceutical development company. It operates in pharmaceutical development, targeting unmet medical needs in fibrosis and oncology through drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, ...

FTSE All-Share

0.3%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

our Investment Fees and Charges.

	0.20p - 0.17p
	0.56p - 0.01p
	-
	4.83m
	-
	2,000,000
	9,564,663
	2.95
	40,594,923.05
	3.28
	2,032.33m
	GB00BYW79Y38
	0.00
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.